1.86 USD
▲+0.12+6.90%
盘后 1.91 +2.69%
2026-11-20
市值
$23.34M
市盈率
—
EPS
-1.21
股息率
—
52 周区间
1.61 – 14.91
成交量
220.68K
Beta
2.84
目标价
18.18
52W 低 1.6152W 高 14.91
价格走势

公司简介

Incannex Healthcare Inc., a clinical-stage biopharmaceutical company, engages in the research and development of psychedelic medicines and therapies for patients with chronic diseases in Australia. The company develops IHL-42X, an oral fixed dose combination of dronabinol and acetazolamide that is in Phase 2/3 clinical trial for the treatment of obstructive sleep apnea; and PSX-001, an oral synthetic psilocybin treatment in Phase 2b clinical development for patients with generalized anxiety disorder. It is developing IHL-675A, an oral fixed dos...